已发表论文

黄连和厚朴药物对及其化学成分、药理作用和药代动力学分析综述

 

Authors Xie Q , Chen J, Yang H, Liang J, Ma R, Guo J, Zeng X

Received 8 May 2024

Accepted for publication 19 September 2024

Published 2 October 2024 Volume 2024:18 Pages 4413—4426

DOI https://doi.org/10.2147/DDDT.S477381

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Tin Wui Wong

Qian Xie, Jiarou Chen, Hongyan Yang, Jianlong Liang, Rong Ma, Jialiang Guo, Xuxin Zeng

School of Medicine, Foshan University, Foshan, 528000, People’s Republic of China

Correspondence: Rong Ma; Xuxin Zeng, School of Medicine, Foshan University, Foshan, 528000, People’s Republic of China, Email 648510213@qq.com; adhesion2002@163.com

Abstract: Herbal pairs are unique combinations of two relatively fixed herbs that are used in clinical practice. This is the most fundamental and straightforward form of multiple herbal treatment that aims to attain specific efficacy through unique methods. Coptidis Rhizoma (“Huanglian” in Chinese) and Magnoliae Officinalis Cortex (“Houpo” in Chinese) which are commonly used in combination and could also be used as important components of other prescriptions to treat damp-heat dysentery, splenic and stomach disorders, and qi stagnation in clinical practice. However, there is currently no summary on the compatibility of Huanglian and Houpo about traditional use, phytochemistry, and pharmacological activity. It was found the combination or separate extraction of the two drugs may affect the main active components, and new components may be produced after the combined extraction. At the same time, Huanglian and Houpo herb pair exhibited antiviral, anti-inflammatory, antibacterial and other pharmacological effects. At present, research mainly focuses on the indicator components of Huanglian and Houpo, such as berberine, magnolol, and magnolol. The models used for pharmacological validation are limited, mainly including ulcerative colitis, pneumonia, bacterial infections, etc. In order to verify the pharmacological activity of the combination of Huanglian and Houpo, it is necessary to try more in vitro and in vivo models. It’s still need to study the compatibility mechanism of the Huanglian and Houpo drug pair, including but not limited to the interactions between different components and the impact of compatibility on efficacy, bioequivalence studies, and the impact of different dosage forms on pharmacokinetics in the future. It’s believed that the systematic review provided comprehensive information for the study of Huanglian-Houpo drug pair, which will help highlight the importance of the Huanglian-Houpo herb pair and provide some clues for future research on this herb pair.

Keywords: Coptidis Rhizoma, Magnoliae Officinalis Cortex, drug pair, chemical constituents, pharmacological effects